These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Investigation of electron boost radiotherapy in patients with breast cancer: Is a direct electron field optimal? Aghili M; Barzegartahamtan M; Alikhassi A; Mohammadpour R Cancer Radiother; 2018 Feb; 22(1):52-56. PubMed ID: 29398305 [TBL] [Abstract][Full Text] [Related]
24. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Giannarini G; Petralia G; Thoeny HC Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497 [TBL] [Abstract][Full Text] [Related]
28. PET/CT and radiotherapy in prostate cancer. De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021 [TBL] [Abstract][Full Text] [Related]
29. Ultrasound in urological oncology. Braeckman J; Keuppens F; Chaban M; Denis L Eur J Surg Oncol; 1987 Dec; 13(6):475-83. PubMed ID: 2446928 [TBL] [Abstract][Full Text] [Related]
30. Urologic cancer. Methods of early detection and future developments. Hricak H Cancer; 1987 Aug; 60(3 Suppl):677-85. PubMed ID: 3297293 [TBL] [Abstract][Full Text] [Related]
31. Urologic cancer in China. Pang C; Guan Y; Li H; Chen W; Zhu G Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022 [TBL] [Abstract][Full Text] [Related]
32. Prostate bed radiation therapy: the utility of ultrasound volumetric imaging of the bladder. Haworth A; Paneghel A; Bressel M; Herschtal A; Pham D; Tai KH; Oates R; Gawthrop J; Cray A; Foroudi F Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):789-96. PubMed ID: 25242000 [TBL] [Abstract][Full Text] [Related]
33. [Use of ultrasonics in irradiation planning]. Weyrauch U; Schoknecht G Strahlentherapie; 1970 May; 139(5):544-7. PubMed ID: 5504313 [No Abstract] [Full Text] [Related]
34. A method for integrating computed tomography into radiotherapy planning and treatment. Ash DV; Andrews B; Stubbs B Clin Radiol; 1983 Jan; 34(1):99-101. PubMed ID: 6822045 [TBL] [Abstract][Full Text] [Related]
35. [Prostatic and bladder cancer--possibilities and limitations of diagnostic imaging]. Stobbe G; Sandring KH Radiol Diagn (Berl); 1990; 31(3):199-204. PubMed ID: 2195581 [TBL] [Abstract][Full Text] [Related]
36. [Magnetic resonance imaging of pelvic tumors in men. Preliminary results in a series of 28 patients]. Marichez M; Despres E; Duclos JM; Bourquelot P; Richard F; Parienty R; Brisset JM; Taieb A Ann Urol (Paris); 1986; 20(4):234-7. PubMed ID: 2427008 [TBL] [Abstract][Full Text] [Related]
38. Current challenges in clinical target volume definition: tumour margins and microscopic extensions. Moghaddasi L; Bezak E; Marcu LG Acta Oncol; 2012 Nov; 51(8):984-95. PubMed ID: 22998477 [TBL] [Abstract][Full Text] [Related]
39. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Button MR; Staffurth JN Clin Oncol (R Coll Radiol); 2010 Oct; 22(8):698-706. PubMed ID: 20688494 [TBL] [Abstract][Full Text] [Related]
40. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours. Seco J; Clark CH; Evans PM; Webb S Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]